Akums Drugs and Pharmaceuticals Limited — Important, 26-05-2025: General Updates

Akums has announced a board meeting approving the financial results for the quarter and half-year. The company reported strong standalone net profit of ₹1610 Cr and consolidated net profit of ₹3438 Cr for FY25. Key highlights include effective IPO fund deployment towards debt repayment and acquisitions, plus overseas expansion through a new UK subsidiary. An Income Tax Department search had no material impact. The CEO of the CDMO business, Mr. Amrut Medhekar, resigned effective 15 July 2025.